SCHEMBL25375800

SCHEMBL25375800

N#Cc1cc(-c2ccc(F)cc2)cc(-c2ccn(C(F)F)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 3/20 0.43
CYP19A1 P11511 1/20 0.42
CSNK1A1 P48729 1/20 0.39
CSNK1D P48730 1/20 0.39
MAPK14 Q16539 1/20 0.39
GRM5 P41594 4/20 0.39
PGR P06401 2/20 0.38
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
BRAF P15056 1/20 0.36
KDR P35968 1/20 0.36
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
CYP1A2 P05177 1/20 0.35
SCN4A P35499 1/20 0.34
MAP4K4 O95819 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30510117 1.00 TGFBR1 (0.43) TGFBR1CYP19A1CSNK1A1CSNK1DMAPK14
SCHEMBL26199262 0.82 SCN4A (0.52) CYP19A1CSNK1A1CSNK1DMAPK14GRM5
SCHEMBL25379116 0.81 SCN9A (0.40) TGFBR1PGRCYP11B1CYP11B2SCN4A
SCHEMBL25379234 0.78 CYP11B1 (0.43) TGFBR1PGRGABRG2GABRB3GABRA5
SCHEMBL30510073 0.78 CYP11B1 (0.43) TGFBR1PGRGABRG2GABRB3GABRA5
SCHEMBL26193069 0.75 TGFBR1 (0.37) TGFBR1PGRGABRG2GABRB3GABRA5
SCHEMBL25380126 0.74 SCN9A (0.44) TGFBR1CYP19A1SCN4A
SCHEMBL30510076 0.74 SCN9A (0.44) TGFBR1CYP19A1SCN4A
SCHEMBL30510067 0.74 MEN1 (0.46) TGFBR1CYP11B1CYP11B2CYP1A2
SCHEMBL25255928 0.74 MEN1 (0.46) TGFBR1CYP11B1CYP11B2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552772-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2026-02-17 US disclosed
US-20250115574-A1 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD VIB VZW (BE) 2025-04-10 US disclosed
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 US disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552772-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 TGFBR1 654/4885CYP19A1 3242/4885CSNK1A1 510/4885
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 TGFBR1 2525/4885CYP19A1 3086/4885CSNK1A1 1566/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 TGFBR1 2525/4885CYP19A1 3086/4885CSNK1A1 1566/4885
US-20250115574-A1 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 TGFBR1 2525/4885CYP19A1 3086/4885CSNK1A1 1566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.